Comparison of the Feasibility and Diagnostic Performance of ACR CEUS LI‐RADS and a Modified CEUS LI‐RADS for HCC in Examinations Using Sonazoid
Journal of Ultrasound in Medicine · 2023
DOI: 10.1002/jum.16282 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Ultrasound in Medicine, 2023. Verfasst von Wei Liao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Ultrasound, The First Affiliated Hospital of Guangxi Medical University, Nanning, China. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Contrast Media, Oxides. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Key Research and Development Project of Qingxiu District, Guangxi Nanning, Clinical Research Climbing Project of The First Affiliated Hospital of Guangxi Medical University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Objectives
The present study aimed to determine the feasibility of the American College of Radiology's (ACR) contrast‐enhanced ultrasound (CEUS) Liver Imaging Reporting and Data System (LI‐RADS) (version 2017) in examinations using Sonazoid and compare its diagnostic performance with that of modified LI‐RADS in patients at high risk of hepatocellular carcinoma (HCC).
Methods
This retrospective study's sample population consisted of 137 participants with a total of 140 nodules who underwent CEUS with Sonazoid and pathological confirmation via surgery or biopsy from January 2020 to February 2022. The lesions were evaluated and classified based on the reference standards (ie, ACR CEUS LI‐RADS and modified LI‐RADS). The overall diagnostic capabilities of the two systems were evaluated in terms of accuracy, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) with 95% confidence intervals (CIs).
Results
The participants had a median age of 51 years and an interquartile range of 43–58 years. Regarding LR‐5 as a predictor of HCC, the accuracy results of the ACR LI‐RADS and modified LI‐RADS algorithms were 72.9 and 71.4%, respectively ( P = .50). The sensitivity of both systems was the same (69.7%; 95% CI: 60.7–77.8%). Regarding LR‐M as a predictor of non‐HCC malignancy, the diagnostic performance of the algorithms was the same, with accuracy and sensitivity results of 76.4 and 73.3%, respectively (95% CI: 44.9–92.2%).
Conclusion
The findings indicate that modified LI‐RADS had a moderate level of diagnostic performance for HCC in examinations using Sonazoid, which was comparable to ACR LI‐RADS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Ultrasound, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
- Guangxi Zhuang Autonomous Region Engineering Research Center for Artificial Intelligence Analysis of Multimodal Tumor Images, Nanning, China.
Förderung
- Key Research and Development Project of Qingxiu District, Guangxi Nanning
- Clinical Research Climbing Project of The First Affiliated Hospital of Guangxi Medical University
- National Natural Science Foundation of China
Zitieren
APA
Liao, W., Que, Q., Wen, R., Lin, P., Chen, Y., Pang, J., Guo, D., Wen, D., Yang, H., & He, Y. (2023). Comparison of the Feasibility and Diagnostic Performance of ACR CEUS LI‐RADS and a Modified CEUS LI‐RADS for HCC in Examinations Using Sonazoid. Journal of Ultrasound in Medicine. https://doi.org/10.1002/jum.16282
Vancouver
Liao W, Que Q, Wen R, Lin P, Chen Y, Pang J, et al. Comparison of the Feasibility and Diagnostic Performance of ACR CEUS LI‐RADS and a Modified CEUS LI‐RADS for HCC in Examinations Using Sonazoid. Journal of Ultrasound in Medicine. 2023. doi:10.1002/jum.16282
BibTeX
@article{Liao2023,
author = {Liao, Wei and Que, Qiao and Wen, Rong and Lin, Peng and Chen, Yuji and Pang, Jinshu and Guo, Danxia and Wen, Dongyue and Yang, Hong and He, Yun},
title = {Comparison of the Feasibility and Diagnostic Performance of ACR CEUS LI‐RADS and a Modified CEUS LI‐RADS for HCC in Examinations Using Sonazoid},
journal = {Journal of Ultrasound in Medicine},
year = {2023},
doi = {10.1002/jum.16282}
}
EUVIMED